Jordan Schaefer is a Hematology physician affiliated with University of Michigan. OpenAlex indexes 93 publications with 1,256 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 East Medical Center Dr
B1 Floor Cancer Recp 'B'
Ann Arbor, MI 481095911
Telephone
734-647-8901Registry record last updated 9 Jan 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- PFIZER INC.Program year20243 payments
- GENZYME CORPORATIONProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
93.4%Factor Xa inhibitor51.3%Eliquis70%Xarelto30%Part D≥19 patientsLow Molecular Weight Heparin24.9%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
6.6%Antimetabolite6.6%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2025 per NIH RePORTER. The latest:
- An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
University of Michigan at Ann Arbor
FY2025$170,853K01HL169920 - An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
University of Michigan at Ann Arbor
FY2024$171,168K01HL169920 - An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
University of Michigan at Ann Arbor
FY2023$171,384K01HL169920
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study
The American Journal of Medicine
2025 - Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study
Journal of Thrombosis and Haemostasis
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”